Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan · Delayed Price · Currency is JPY 2,061.00
-8.00 (-0.39%)
Aug 4, 2026, 12:33 PM JST
Zeria Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 91,200 | 94,559 | 99,488 | 93,978 | 98,960 | 85,331 | |
Market Cap Growth | -2.27% | -4.95% | 5.86% | -5.03% | 15.97% | -11.23% |
Enterprise Value | 102,751 | 111,466 | 119,281 | 125,376 | 134,397 | 126,409 |
Last Close Price | 2069.00 | 2195.00 | 2206.28 | 2041.81 | 2108.01 | 1754.60 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 10.79 | 11.19 | 10.01 | 12.16 | 15.97 | 21.54 |
Forward PE | 8.77 | 10.40 | 10.13 | 11.34 | 12.53 | 20.60 |
PS Ratio | 1.02 | 1.06 | 1.14 | 1.24 | 1.45 | 1.43 |
PB Ratio | 0.84 | 0.87 | 1.11 | 1.18 | 1.51 | 1.55 |
P/TBV Ratio | 1.33 | 1.37 | 2.02 | 2.58 | 4.21 | 6.23 |
P/FCF Ratio | 12.01 | 12.45 | 8.66 | 10.12 | 9.20 | 10.82 |
P/OCF Ratio | 9.16 | 9.50 | 7.70 | 7.71 | 7.52 | 9.53 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.15 | 1.25 | 1.37 | 1.66 | 1.97 | 2.12 |
EV/EBITDA Ratio | 5.26 | 5.65 | 6.04 | 7.30 | 8.86 | 10.74 |
EV/EBIT Ratio | 8.43 | 9.01 | 9.78 | 13.03 | 14.91 | 19.86 |
EV/FCF Ratio | 13.53 | 14.68 | 10.38 | 13.51 | 12.49 | 16.03 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.36 | 0.36 | 0.46 | 0.58 | 0.75 | 0.95 |
Debt / EBITDA Ratio | 1.98 | 1.98 | 2.08 | 2.69 | 3.26 | 4.44 |
Debt / FCF Ratio | 5.15 | 5.15 | 3.58 | 4.98 | 4.60 | 6.62 |
Net Debt / Equity Ratio | 0.10 | 0.10 | 0.20 | 0.32 | 0.51 | 0.74 |
Net Debt / EBITDA Ratio | 0.57 | 0.57 | 0.89 | 1.51 | 2.19 | 3.44 |
Net Debt / FCF Ratio | 1.49 | 1.49 | 1.53 | 2.79 | 3.09 | 5.14 |
Asset Turnover | 0.53 | 0.53 | 0.56 | 0.53 | 0.53 | 0.48 |
Inventory Turnover | 1.29 | 1.29 | 1.51 | 1.48 | 1.53 | 1.51 |
Quick Ratio | 1.05 | 1.05 | 0.92 | 0.76 | 0.71 | 0.63 |
Current Ratio | 1.48 | 1.48 | 1.28 | 1.06 | 1.02 | 0.94 |
Return on Equity (ROE) | 8.48% | 8.48% | 11.75% | 10.58% | 10.28% | 7.14% |
Return on Assets (ROA) | 4.57% | 4.57% | 4.92% | 4.21% | 4.35% | 3.23% |
Return on Invested Capital (ROIC) | 7.99% | 8.18% | 9.04% | 7.61% | 7.91% | 4.61% |
Return on Capital Employed (ROCE) | 10.00% | 10.00% | 11.60% | 10.00% | 10.30% | 7.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 9.27% | 8.94% | 9.99% | 8.23% | 6.26% | 4.64% |
FCF Yield | 8.33% | 8.03% | 11.55% | 9.88% | 10.87% | 9.24% |
Dividend Yield | 2.39% | 2.23% | 2.13% | 2.15% | 1.90% | 1.99% |
Payout Ratio | 24.96% | 24.96% | 19.89% | 25.03% | 25.67% | 38.83% |
Buyback Yield / Dilution | - | 0.00% | 0.00% | 0.21% | 2.14% | 2.02% |
Total Shareholder Return | 2.39% | 2.23% | 2.13% | 2.37% | 4.04% | 4.02% |